Strep A: challenges, opportunities, vaccine-based solutions, and economics

David E Bloom; Jonathan Carapetis

doi:10.1038/s41541-024-00863-7

Strep A: challenges, opportunities, vaccine-based solutions, and economics

NPJ Vaccines. 2024 Apr 19;9(1):80. doi: 10.1038/s41541-024-00863-7.

Authors

David E Bloom¹, Jonathan Carapetis^{2

3}

Affiliations

¹ Harvard T.H. Chan School of Public Health, Boston, MA, USA. dbloom@hsph.harvard.edu.
² Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, WA, Australia.
³ Perth Children's Hospital, Perth, WA, Australia.

Abstract

This collection of articles focuses on Streptococcus pyogenes (Strep A) vaccine research and innovation, with a focus on emerging efforts to understand and estimate the full societal value of Strep A vaccination.

Publication types

Review

Grants and funding

WT_/Wellcome Trust/United Kingdom